Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation on the Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy: A Prospective Randomized Clinical Trial

NCT02838121 is registered in ClinicalTrials.gov with Mel Shiuann-Sheng Lee as lead sponsor.

NCT NCT02838121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02838121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation on the Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy: A Prospective Randomized Clinical Trial
Lead sponsor
Mel Shiuann-Sheng Lee
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2009
Completion date
June 30, 2016
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

functional outcomes, prevention of bmd loss after thr, serum markers of bone turnover